Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM and AL Amyloidosis Highlighting Marked Improvement in ORR 2024-06-18 12:43
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including Encouraging Data from US Study in CML and Ph+ ALL 2024-06-18 12:23
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions 2024-06-18 12:13
Leading the Digital Revolution for Health: European Wellness and QBeep Launches Groundbreaking "SmartMFDealers" App 2024-06-18 08:00
Chinese Team Secures "Best Showpiece Award" at the 52nd UIBC International Competition for Young Bakers with Angel Yeast's Support 2024-06-17 15:17
ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research 2024-06-17 10:00
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI) 2024-06-14 21:30
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary 2024-06-14 08:34
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy 2024-06-13 18:03
NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore 2024-06-13 10:00
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2024-06-13 08:00
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions 2024-06-12 08:00
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE 2024-06-11 11:25
India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad 2024-06-10 15:40
deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans 2024-06-07 23:00
IONETIX Produces First Batch of Actinium-225 2024-06-07 20:27
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024 2024-06-07 19:00
Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma 2024-06-07 16:51
MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease 2024-06-07 15:00
1 12 13 14 15 16 229